List of Sun Pharmaceutical patents

Patents where

Current Assignee

Name

Sun Pharmaceutical

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10345602 Microdisplay based immersive headset	Patent 10345602 was granted and assigned to Sun Pharmaceutical on July, 2019 by the United States Patent and Trademark Office.	EMagin	Sun Pharmaceutical	United States Patent and Trademark Office	10345602	July 9, 2019
‌ US Patent 7482471 Process for preparation of 1-[9H-carbazol-4-yloxy]-3-[{2-(2-(-methoxy)phenoxy)-ethyl}-amino]-propan-2-ol	Patent 7482471 was granted and assigned to Sun Pharmaceutical on January, 2009 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	7482471	January 27, 2009
‌ US Patent 11504345 Extended release liquid compositions of metformin	Patent 11504345 was granted and assigned to Sun Pharmaceutical on November, 2022 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	11504345	November 22, 2022
‌ US Patent 11523996 Extended release liquid compositions of metformin	Patent 11523996 was granted and assigned to Sun Pharmaceutical on December, 2022 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	11523996	December 13, 2022
‌ US Patent 11510878 Extended release multiparticulates of ranolazine	Patent 11510878 was granted and assigned to Sun Pharmaceutical on November, 2022 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	11510878	November 29, 2022
‌ US Patent 9622979 Multilayered dosage form	Patent 9622979 was granted and assigned to Sun Pharmaceutical on April, 2017 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	9622979	April 18, 2017
‌ US Patent 7208613 Synthesis of s-fluoromethyl 6α,9α-difluoro-11β-hydroxy-16α-methyl-17α-propionyloxy-3-oxoandrosta-1,4-diene-17β-carbothioate	Patent 7208613 was granted and assigned to Sun Pharmaceutical on April, 2007 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	7208613	April 24, 2007
‌ US Patent 11447535 GLP-1 analogues	Patent 11447535 was granted and assigned to Sun Pharmaceutical on September, 2022 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	11447535	September 20, 2022
‌ US Patent 10238803 Drug delivery device for pharmaceutical compositions	Patent 10238803 was granted and assigned to Sun Pharmaceutical on March, 2019 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	10238803	March 26, 2019
‌ US Patent 7550605 Process for preparation of an anitdepressant compound	Patent 7550605 was granted and assigned to Sun Pharmaceutical on June, 2009 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	7550605	June 23, 2009
‌ US Patent 10098813 Perfusion dosage form	Patent 10098813 was granted and assigned to Sun Pharmaceutical on October, 2018 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	10098813	October 16, 2018
‌ US Patent 9682081 Pharmaceutical gastro-retentive solid oral dosage form of nilotinib	Patent 9682081 was granted and assigned to Sun Pharmaceutical on June, 2017 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	9682081	June 20, 2017
‌ US Patent 9938283 Crystalline form of baricitinib	Patent 9938283 was granted and assigned to Sun Pharmaceutical on April, 2018 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	9938283	April 10, 2018
‌ US Patent 10138221 Salts of nilotinib and polymorphs thereof	Patent 10138221 was granted and assigned to Sun Pharmaceutical on November, 2018 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	10138221	November 27, 2018
‌ US Patent 9707261 Anti dengue activity of	Patent 9707261 was granted and assigned to Sun Pharmaceutical on July, 2017 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	9707261	July 18, 2017
‌ US Patent 9241948 Ready to be infused gemcetabine solution	Patent 9241948 was granted and assigned to Sun Pharmaceutical on January, 2016 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	9241948	January 26, 2016
‌ US Patent 7132444 Process for the preparation of trans-3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methyl cyclohexyl) amino]carbonyl]amino]sulfonyl] phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide	Patent 7132444 was granted and assigned to Sun Pharmaceutical on November, 2006 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	7132444	November 7, 2006
‌ US Patent 7105178 Cardiotonic composition	Patent 7105178 was granted and assigned to Sun Pharmaceutical on September, 2006 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	7105178	September 12, 2006
‌ US Patent 7411087 Process for preparation of bisphosphonic acid compounds	Patent 7411087 was granted and assigned to Sun Pharmaceutical on August, 2008 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	7411087	August 12, 2008
‌ US Patent 9365526 Process for the preparation of dasatinib and its intermediates	Patent 9365526 was granted and assigned to Sun Pharmaceutical on June, 2016 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	9365526	June 14, 2016
‌ US Patent 9561242 Doxycycline composition	Patent 9561242 was granted and assigned to Sun Pharmaceutical on February, 2017 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	9561242	February 7, 2017
‌ US Patent 9566287 Pharmaceutical composition of doxycycline with reduced food effect	Patent 9566287 was granted and assigned to Sun Pharmaceutical on February, 2017 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	9566287	February 14, 2017
‌ US Patent 9463196 Pharmaceutical composition of doxycycline with reduced food effect	Patent 9463196 was granted and assigned to Sun Pharmaceutical on October, 2016 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	9463196	October 11, 2016
‌ US Patent 9572777 Topical pharmaceutical composition comprising nanonized silver sulfadiazine	Patent 9572777 was granted and assigned to Sun Pharmaceutical on February, 2017 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	9572777	February 21, 2017
‌ US Patent 9433580 Topical pharmaceutical composition comprising nanonized silver sulfadiazine	Patent 9433580 was granted and assigned to Sun Pharmaceutical on September, 2016 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	9433580	September 6, 2016

Results per page:

99 results

0 selected

99 results

0 selected